Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model

被引:5
|
作者
Khalili, Dilan [1 ]
Kalcher, Christina [1 ]
Baumgartner, Stefan [2 ]
Theopold, Ulrich [1 ]
机构
[1] Stockholm Univ, Wenner Gren Inst MBW, Dept Mol Biosci, Stockholm, Sweden
[2] Lund Univ, Dept Expt Med Sci, Lund, Sweden
基金
瑞典研究理事会;
关键词
Fibrosis; Antimicrobial peptides; Insect immunity; Innate immunity; Extracellular matrix;
D O I
10.1159/000516104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fibrotic lesions accompany several pathological conditions, including tumors. We show that expression of a dominant-active form of the Ras oncogene in Drosophila salivary glands (SGs) leads to redistribution of components of the basement membrane (BM) and fibrotic lesions. Similar to several types of mammalian fibrosis, the disturbed BM attracts clot components, including insect transglutaminase and phenoloxidase. SG epithelial cells show reduced apicobasal polarity accompanied by a loss of secretory activity. Both the fibrotic lesions and the reduced cell polarity are alleviated by ectopic expression of the antimicrobial peptide drosomycin (Drs), which also restores the secretory activity of the SGs. In addition to extracellular matrix components, both Drs and F-actin localize to fibrotic lesions.
引用
收藏
页码:376 / 390
页数:15
相关论文
共 50 条
  • [41] Anti-Remodeling and Anti-Fibrotic Effects of the Neuregulin-1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure
    Galindo, Cristi L.
    Kasasbeh, Ehab
    Murphy, Abigail
    Ryzhov, Sergey
    Lenihan, Sean
    Ahmad, Farhaan A.
    Williams, Philip
    Nunnally, Amy
    Adcock, Jamie
    Song, Yanna
    Harrell, Frank E.
    Truc-Linh Tran
    Parry, Tom J.
    Iaci, Jen
    Ganguly, Anindita
    Feoktistov, Igor
    Stephenson, Matthew K.
    Caggiano, Anthony O.
    Sawyer, Douglas B.
    Cleator, John H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (05):
  • [42] Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease
    Choi, Shinkyu
    Kim, Ji Aee
    Li, Haiyan
    Jo, Seong-Eun
    Lee, Huisu
    Kim, Tae Hun
    Kim, Minje
    Kim, Seong-Jin
    Suh, Suk Hyo
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 144
  • [43] Anti-fibrotic effects of Silimarit® dry extract in the STAM™ model of non-alcoholic steatohepatitis
    Peterburs, P.
    Ammendola, A.
    Lechner, A.
    PLANTA MEDICA, 2016, 82
  • [44] Cardiac fibroblasts on the fast track - Scleraxis: From Achilles' heel to anti-fibrotic therapy
    Kardasinski, Michal
    Thum, Thomas
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 47 (02) : 174 - 176
  • [45] Pro- and anti-fibrotic effects of TGF-β in scleroderma
    Sgonc, R.
    Wick, G.
    RHEUMATOLOGY, 2008, 47 : V5 - V7
  • [46] HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease
    Mizuno, Shinya
    Matsumoto, Kunio
    Nakamura, Toshikazu
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 7072 - U170
  • [47] Promising Anti-Fibrotic Approaches for Future Treatment of Systemic Sclerosis
    Distler, Joerg H. W.
    Distler, Oliver
    CURRENT RHEUMATOLOGY REVIEWS, 2010, 6 (04) : 305 - 308
  • [48] Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib
    Bellamri, Nessrine
    Morzadec, Claudie
    Joannes, Audrey
    Lecureur, Valerie
    Wollin, Lutz
    Jouneau, Stephane
    Vernhet, Laurent
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 72 : 112 - 123
  • [49] Anti-fibrotic mechanisms of angiotensin AT2-receptor stimulation
    Sumners, Colin
    Peluso, Antonio Augusto
    Haugaard, Andreas Houe
    Bertelsen, Jesper Bork
    Steckelings, Ulrike Muscha
    ACTA PHYSIOLOGICA, 2019, 227 (01)
  • [50] Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties
    Marzaro, Giovanni
    Castagliuolo, Ignazio
    Schirato, Giulia
    Palu, Giorgio
    Dalla Via, Martina
    Chilin, Adriana
    Brun, Paola
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 115 : 416 - 425